Skip to main content
. 2019 Nov 14;12:9707–9713. doi: 10.2147/OTT.S230406

Table 3.

Efficacy Of Apatinib In Patients With Cervical Cancer

n=25 95% CI
Median PFS (months) 5.8 4.65–6.95
Median OS (months) 12.2 8.99–15.41
Tumor response
 PR (%) 12 (48)
 SD (%) 12 (48)
 PD (%) 1 (4)
ORR 48%
DCR 96%

Abbreviations: PFS, progression-free survival; OS, overall survival; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate; CI, confidence interval.